Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109870

Thromboxane A2 Mediates Augmented Polymorphonuclear Leukocyte Adhesiveness

Philip J. Spagnuolo, Jerrold J. Ellner, Aviv Hassid, and Michael J. Dunn

Departments of Medicine, Veterans Administration Hospital and University Hospitals of Cleveland, Cleveland, Ohio 44106

Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106

Find articles by Spagnuolo, P. in: PubMed | Google Scholar

Departments of Medicine, Veterans Administration Hospital and University Hospitals of Cleveland, Cleveland, Ohio 44106

Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106

Find articles by Ellner, J. in: PubMed | Google Scholar

Departments of Medicine, Veterans Administration Hospital and University Hospitals of Cleveland, Cleveland, Ohio 44106

Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106

Find articles by Hassid, A. in: PubMed | Google Scholar

Departments of Medicine, Veterans Administration Hospital and University Hospitals of Cleveland, Cleveland, Ohio 44106

Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106

Find articles by Dunn, M. in: PubMed | Google Scholar

Published September 1, 1980 - More info

Published in Volume 66, Issue 3 on September 1, 1980
J Clin Invest. 1980;66(3):406–414. https://doi.org/10.1172/JCI109870.
© 1980 The American Society for Clinical Investigation
Published September 1, 1980 - Version history
View PDF
Abstract

We examined the role of prostaglandins and thromboxanes as mediators of plasma-dependent increased polymorphonuclear leukocyte adhesiveness induced by Escherichia coli lipopolysaccharide. The cyclo-oxygenase inhibitors—indomethacin and d,l-6-chloro-α-methyl-carbozole-2-acetic acid (R020-5720)—reduced lipopolysaccharide-induced adherence of polymorphonuclear leukocytes by 74 and 62%, respectively. In addition, inhibitors of thromboxane synthetase—imidazole, 9,11-azoprosta-5,13-dienoic acid, and 1-benzylimidazole—suppressed the stimulation of adherence by 31, 66, and 83%, respectively. Exogenous prostaglandins E1, E2, and F2α did not increase polymorphonuclear leukocyte adherence, nor were they detected in significant quantities in supernates of polymorphonuclear leukocytes exposed to lipopolysaccharide. However, inhibitors of both cyclo-oxygenase and thromboxane synthetase reduced increases in adherence induced by arachidonic acid (10 μg/ml), suggesting that lipopolysaccharide-mediated increases in adherence were due to an arachidonic acid product other than prostaglandin E2 or F2α. 8,11,14-Eicosatrienoic acid, a precursor of monoenoic prostaglandins, did not enhance polymorphonuclear leukocyte adhesiveness.

We next demonstrated lipopolysaccharide-stimulated generation, by polymorphonuclear leukocytes, of a labile, low molecular weight, dialyzable substance capable of enhancing the adherence of unstimulated leukocytes. In parallel experiments, a 10-fold increase in immunoreactive thromboxane B2 over basal levels was detected after exposure of leukocytes to lipopolysaccharide. The inhibition of lipopolysaccharide enhancement of adherence by specific rabbit antibodies to thromboxane B2 strongly supported a primary role for thromboxane A2 as the mediator of the observed increases in adherence. Lipopolysaccharide-stimulated purified platelets did not increase leukocyte adherence, whereas thrombin-stimulated platelets did increase adherence.

These studies suggest that lipopolysaccharide stimulates polymorphonuclear leukocytes to produce thromboxane A2, which enhances their adhesiveness to nylon.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 406
page 406
icon of scanned page 407
page 407
icon of scanned page 408
page 408
icon of scanned page 409
page 409
icon of scanned page 410
page 410
icon of scanned page 411
page 411
icon of scanned page 412
page 412
icon of scanned page 413
page 413
icon of scanned page 414
page 414
Version history
  • Version 1 (September 1, 1980): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts